Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23677615)

1.

IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG).

Zirkel A, Lederer M, Stöhr N, Pazaitis N, Hüttelmaier S.

Nucleic Acids Res. 2013 Jul;41(13):6618-36. doi: 10.1093/nar/gkt410. Epub 2013 May 15.

2.

IGF2BP1: a post-transcriptional "driver" of tumor cell migration.

Stöhr N, Hüttelmaier S.

Cell Adh Migr. 2012 Jul-Aug;6(4):312-8. doi: 10.4161/cam.20628. Epub 2012 Jul 1.

3.

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.

Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S.

PLoS One. 2012;7(7):e40378. doi: 10.1371/journal.pone.0040378. Epub 2012 Jul 20.

4.

The transcription factor LEF-1 induces an epithelial-mesenchymal transition in MDCK cells independent of β-catenin.

Kobayashi W, Ozawa M.

Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):133-8. doi: 10.1016/j.bbrc.2013.11.031. Epub 2013 Nov 19.

PMID:
24269234
5.

Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.

Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C, Moran MS, Shao C, Yang Q.

Cancer Sci. 2011 Jun;102(6):1151-7. doi: 10.1111/j.1349-7006.2011.01919.x. Epub 2011 Apr 5.

PMID:
21371176
6.

Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription.

Christova T, Mojtahedi G, Hamel PA.

Int J Biochem Cell Biol. 2010 May;42(5):630-40. doi: 10.1016/j.biocel.2009.12.006. Epub 2009 Dec 16.

PMID:
20006729
7.

E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression.

Solanas G, Porta-de-la-Riva M, Agustí C, Casagolda D, Sánchez-Aguilera F, Larriba MJ, Pons F, Peiró S, Escrivà M, Muñoz A, Duñach M, de Herreros AG, Baulida J.

J Cell Sci. 2008 Jul 1;121(Pt 13):2224-34. doi: 10.1242/jcs.021667.

8.

Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.

Huang FI, Chen YL, Chang CN, Yuan RH, Jeng YM.

Carcinogenesis. 2012 Jun;33(6):1142-8. doi: 10.1093/carcin/bgs131. Epub 2012 Mar 20.

9.

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.

Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S, Squire J, Park PC, Feilotter H.

BMC Cancer. 2012 Mar 19;12:91. doi: 10.1186/1471-2407-12-91.

10.

Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.

Wels C, Joshi S, Koefinger P, Bergler H, Schaider H.

J Invest Dermatol. 2011 Sep;131(9):1877-85. doi: 10.1038/jid.2011.142. Epub 2011 May 19.

11.

TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug.

Slabáková E, Pernicová Z, Slavíčková E, Staršíchová A, Kozubík A, Souček K.

Prostate. 2011 Sep;71(12):1332-43. doi: 10.1002/pros.21350. Epub 2011 Feb 14.

PMID:
21321977
12.

Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.

Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.

Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.

13.

IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.

Stöhr N, Köhn M, Lederer M, Glass M, Reinke C, Singer RH, Hüttelmaier S.

Genes Dev. 2012 Jan 15;26(2):176-89. doi: 10.1101/gad.177642.111.

15.

Lef1 is required for the transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic mammary gland.

Boras-Granic K, Chang H, Grosschedl R, Hamel PA.

Dev Biol. 2006 Jul 1;295(1):219-31. Epub 2006 Apr 3.

16.

A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition.

Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, Yook JI.

J Cell Biol. 2011 Oct 31;195(3):417-33. doi: 10.1083/jcb.201103097. Epub 2011 Oct 24.

17.

The putative tumor suppressor VILIP-1 counteracts epidermal growth factor-induced epidermal-mesenchymal transition in squamous carcinoma cells.

Schönrath K, Klein-Szanto AJ, Braunewell KH.

PLoS One. 2012;7(3):e33116. doi: 10.1371/journal.pone.0033116. Epub 2012 Mar 30.

18.

Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.

Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, Lee MT.

Cancer Sci. 2011 Apr;102(4):815-27. doi: 10.1111/j.1349-7006.2011.01861.x. Epub 2011 Feb 9.

PMID:
21219539
19.

Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.

Techasen A, Namwat N, Loilome W, Bungkanjana P, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H, Yongvanit P.

Med Oncol. 2012 Dec;29(5):3083-91. doi: 10.1007/s12032-012-0305-x. Epub 2012 Aug 19.

PMID:
22903530
20.

Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.

Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB, Ivaska J.

Oncogene. 2011 Mar 24;30(12):1436-48. doi: 10.1038/onc.2010.509. Epub 2010 Nov 8.

PMID:
21057535
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk